- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06536153
Maternal Under-nutrition and Effect of Amaranth Grain Flat-bread on Anemia
Maternal Under-nutrition and Effect of Amaranth Grain Flat-bread on Anemia in Northern Zone of Sidama Region, Ethiopia.
Introduction: In Ethiopia, maternal malnutrition is a severe public health issue. Underweight and anaemia are the two most common nutritional problems in pregnant women, and they often coexist.
Methods: A community-based cross-sectional study will be undertaken on a sample of 528 pregnant women in their first trimester to investigate the prevalence of anemia and associated risk factors, as well as the prevalence of co-existing anemia and undernutrition. Following that, a six-month parallel-group community-based randomized controlled trial will be conducted among 306 anemic women to assess the effect of locally prepared amaranth grain flatbread on hemoglobin concentration and anemia prevalence when compared to maize bread, which is commonly consumed among pregnant women.
Study Overview
Status
Intervention / Treatment
Detailed Description
Introduction: In Ethiopia, maternal malnutrition is a major public health concern. Underweight and anaemia are the two most common nutritional disorders in pregnant women, and they frequently co-exist. A prevalent kind of nutritional anaemia is iron-deficiency anaemia (IDA). These issues are primarily caused by a lack of important micro and macronutrients in the diet, as pregnant women eat primarily cereal-based foods. As a result, the burden of under-nutrition in Ethiopia necessitates a more in-depth investigation of underused crops that are high in nutrients and have the potential to minimize food and nutrition insecurity. Although the amaranth plant grows widely in Ethiopia and can boost food intake, its nutritional potential has yet to be acknowledged by community consumers and health professionals.
Methods: A community-based cross-sectional study will be conducted on a sample of 528 pregnant women in their first trimester to examine the prevalence of anemia and identify its risk factors and determine the prevalence of co-existing anemia and under-nutrition among pregnant women. From pregnant women who will be diagnosed for anemia, C-reactive protein (CRP) and serum ferritin will be analyzed to determine IDA. Following this, a parallel-group community-based randomized controlled trial will be conducted for six months among 306 anemic women to evaluate the effect of locally prepared amaranth grain flat-bread on hemoglobin concentration and anemia prevalence compared to the frequently consumed maize bread among pregnant women. A multi-stage sampling method will be utilized to select eligible pregnant women. The households with pregnant women will be identified by conducting the house-to-house census.For categorical variables, summary measures will be presented as absolute frequencies and percentages, but for numerical variables, the mean with standard deviation (SD) will be utilized as a descriptive measure after the distribution is checked for normality. A multi-level mixed-effect logistic/linear regression model will be used to account for between and with cluster effects. We will be used intention-to-treat analyses approach.
Study Type
Enrollment (Estimated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: Embialle MI Beyene, PhD
- Phone Number: +251929285443
- Email: embialle@yahoo.com
Study Contact Backup
- Name: Amanuel Ej Debiso, Masters
- Phone Number: +251916450685
- Email: aejeso@yahoo.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pregnant women less than 3 months of gestational age and residing in the district for at least 6 months.
Exclusion Criteria:
- Women who have a severe illness during the data collection period
- Women who have a psychiatric disorder
- Women who have plan to change residence during the implementation of an intervention
- Women who have chronic diseases like tuberculosis, HIV/AIDS, and cancer
- women who received blood transfusion in the last 6 months
- Women who have had malaria at least 3 times in the last 3 months
- Women with severe anemia (<7 g/dl) detected during the survey
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Amaranth arm
The pregnant women in the experimental group will be referred as the "amaranth arm".
Pregnant women in the intervention arm (N = 153) will receive 200 g of flat-bread on a daily basis, comprising 30% chickpea and 70% amaranth grain in mass, for six months.
|
The recipe will be produced according to the recommended dietary allowance (RDA); based on RDA, 200 g of flat-bread (30% chickpea and 70% amaranth grain) comprised 30 mg of iron, which can satisfy 50% of RDA supposing 15-20% iron absorption (54).
A prior study concluded that the acceptability was satisfactory in the community (55).
Also, a study from the Hawassa University Department of Food Sciences reported that amaranth-grain flat-bread was safe for consumption for 48 hours after preparation and improved the nutritional values (56).
To lower the phytate levels in the amaranth grain, home-level processing will be used.
For 24 hours, amaranth grain will be soaked in water with 5 milliliters of lemon juice per 100 milliliters of water, and it will germinate for 72 hours.
It will be sun-dried, roasted, and ground using a nearby electrical mill before fermented bread is made
|
|
Active Comparator: Maize arm
The pregnant women in the control group will be referred as the "maize arm".
Pregnant women in the control arm (N = 153) will receive 200 g of bread on a daily basis, comprising 100% maize, for six months.
|
The recipe will be produced according to the recommended dietary allowance (RDA); based on RDA, 200 g of flat-bread (30% chickpea and 70% amaranth grain) comprised 30 mg of iron, which can satisfy 50% of RDA supposing 15-20% iron absorption (54).
A prior study concluded that the acceptability was satisfactory in the community (55).
Also, a study from the Hawassa University Department of Food Sciences reported that amaranth-grain flat-bread was safe for consumption for 48 hours after preparation and improved the nutritional values (56).
To lower the phytate levels in the amaranth grain, home-level processing will be used.
For 24 hours, amaranth grain will be soaked in water with 5 milliliters of lemon juice per 100 milliliters of water, and it will germinate for 72 hours.
It will be sun-dried, roasted, and ground using a nearby electrical mill before fermented bread is made
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of anemia
Time Frame: Up to six months
|
In pregnancy, anemia is defined as Hemoglobin <11 g/dl and is classified into three categories based on WHO criteria: mild (10.0-10.9
g/dl), moderate (7.0-9.9 g/dl), and severe (7.0 g/dl)
|
Up to six months
|
|
Prevalence of under-nutrition
Time Frame: Up to six months
|
In this study, the MUAC measurements of pregnant mothers who fall below a cutoff point of 23 cm will be classified as undernourished, while those who measure 23 cm or more will be classified as normal.
|
Up to six months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Amanuel Yo Samago, Masters, Hawassa University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB/027/16
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Maternal; Malnutrition, Affecting Fetus
-
Bezmialem Vakif UniversityCompletedSurgery; Maternal, Uterus or Pelvic Organs, Affecting FetusTurkey (Türkiye)
-
University Hospital, CaenAmiens University HospitalUnknownSurgery; Maternal, Uterus or Pelvic Organs, Affecting FetusFrance
-
University Hospitals Cleveland Medical CenterWithdrawnBreast Feeding | Fentanyl | Nalbuphine | Maternal Anaesthesia and Analgesia Affecting Fetus or Newborn | BupivacaineUnited States
-
RTI InternationalNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Medical Research...CompletedMaternal; Alcohol Use, Affecting FetusSouth Africa
-
Karamanoğlu Mehmetbey UniversityCompletedPregnancy Related | Cesarean Delivery Affecting Fetus | Fetus FetusTurkey
-
University Hospital, Strasbourg, FranceRecruitingAmniocentesis Affecting FetusFrance
-
St George's, University of LondonSt George's University Hospitals NHS Foundation TrustCompletedCMV | Congenital Cmv | Maternal Infections Affecting Fetus or Newborn | Shedding VirusUnited Kingdom
-
Tzu-Ying HuangCompletedMaternal Infections Affecting Fetus or Newborn | Cost Effectiveness | Perineal InfectionTaiwan
-
Assiut UniversityUnknownUmbilical Cord; Complications, Affecting Fetus
-
Charite University, Berlin, GermanyCompletedCesarean Section Complications | Cesarean Delivery Affecting Newborn | Cesarean Delivery Affecting FetusGermany
Clinical Trials on Amaranth grain flat bread
-
University of Illinois at Urbana-ChampaignRecruitingCardiovascular Diseases | Dysbiosis | Gastrointestinal Dysfunction | Nutritional and Metabolic DiseasesUnited States
-
Örebro University, SwedenCompleted
-
Chalmers University of TechnologySahlgrenska University Hospital, SwedenCompletedAnaemia | Iron Bioavailability
-
Marjukka KolehmainenWageningen University; VTT Technical Research Centre, FinlandCompletedObesity | Metabolic Syndrome | Impaired Glucose Tolerance | Impaired Fasting GlucoseFinland